Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Rheumatology|December 1, 1994
An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophanD Michelson, S W Page, R Casey, et al.
The Journal of Clinical Investigation|February 1, 1984
Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterinR R McInnes, S Kaufman, J J Warsh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 23, 2014
Factors associated with returning to HIV care after a gap in care in New York StateChinazo O Cunningham, Johanna Buck, Fiona M Shaw, et al.
Molecular Biology of the Cell|April 10, 1999
Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1C H Liu, S Thangada, M J Lee, et al.
Nature|June 27, 1996
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphateO Cuvillier, G Pirianov, B Kleuser, et al.
Journal of Neurophysiology|May 16, 2001
Time-resolved fMRI of activation patterns in M1 and SMA during complex voluntary movementF Weilke, S Spiegel, H Boecker, et al.
Blood|February 7, 2001
Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6J R Van Brocklyn, M H Gräler, G Bernhardt, et al.
Cellular and Molecular Life Sciences : CMLS|December 20, 2003
Sphingosine 1-phosphate signal survival and mitogenesis are mediated by lipid-stereospecific binding of triacylglycerol-rich lipoproteinsY M Pacheco, R Abia, A Olivera, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infectionA Krämer, S Z Wiktor, D Fuchs, et al.
Pageof 26